Nuzenio

Ivonescimab Phase Ib

Ivonescimab Phase Ib news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 5 latest news signals 4 publisher sources 100/100 entity strength

Latest news

Summit Therapeutics begins Phase II/III HARMONi-GU1 study of ivonescimab - YahooYahoo · Thu, 06 Aug 2026 10:46:44 GMT Akeso Doses First Patient in AK138D1 + Ivonescimab Phase Ib/II Lung Cancer Study - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 28 Jul 2026 06:56:04 GMT Pacira Completes Manufacturing Transition in PCRX-201 Phase 2 Trial - The Clinical Trial VanguardThe Clinical Trial Vanguard · Tue, 28 Jul 2026 06:56:04 GMT Akeso IO2.0 + ADC2.0 Strategy Makes Another Advancement: First Patient Dosed in Phase Ib/II Study of HER3 ADC (AK138D1) Combined with Ivonescimab in Lung Cancer - finance.yahoo.comfinance.yahoo.com · Mon, 27 Jul 2026 07:00:00 GMT Summit, Merck must navigate new regulatory terrain in China-first cancer landscape - BioSpaceBioSpace · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 10:46:44 GMTSummit Therapeutics begins Phase II/III HARMONi-GU1 study of ivonescimab - Yahoo

Tue, 28 Jul 2026 06:56:04 GMTAkeso Doses First Patient in AK138D1 + Ivonescimab Phase Ib/II Lung Cancer Study - The Clinical Trial Vanguard

Tue, 28 Jul 2026 06:56:04 GMTPacira Completes Manufacturing Transition in PCRX-201 Phase 2 Trial - The Clinical Trial Vanguard

Mon, 27 Jul 2026 07:00:00 GMTAkeso IO2.0 + ADC2.0 Strategy Makes Another Advancement: First Patient Dosed in Phase Ib/II Study of HER3 ADC (AK138D1) Combined with Ivonescimab in Lung Cancer - finance.yahoo.com

Mon, 27 Jul 2026 07:00:00 GMTSummit, Merck must navigate new regulatory terrain in China-first cancer landscape - BioSpace

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Phase II2 live mentions III HARMONi2 live mentions II Lung Cancer2 live mentions The Clinical Trial2 live mentions Trial Vanguard The2 live mentions Clinical Trial Vanguard2 live mentions PCRX2 live mentions Phase2 live mentions Akeso2 live mentions Strategy Makes Another2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ivonescimab Phase Ib.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

4 distinct publisher/source names are currently connected to this entity page.